| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-05 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |